Abstract
Background: Recent advances in the understanding of RNA structure-function, intricate folding and its affinity to bind small molecules have led to the proposal that RNA can be a fastidious target for drug design. The revelation that RNA can act as enzymes as in group I intron and that has been recognized by small molecule ligands targeting the catalytic activity has necessitated our focus on group I intron as target for RNA binders. Methods: We studied the group I intron splicing of Tetrahymena in the presence of naturally occurring methylxanthines (theophylline, theobromine and caffeine) at 5-200 μmol/l concentration, and analyzed the spliced out products. For the first time the interference of splicing was ascertained on the basis of pre-rRNA accumulation. Results: The gel mobility shift showed the binding of methylxanthines with group I intron RNA in a dose dependent manner. The densitometric analysis of pre-rRNA accumulation showed 50% of splicing interference at 200 μmol/l of theophylline and theobromine, whereas the structurally similar molecule caffeine does not alter splicing. Conclusion: The splicing interference measured from the accumulation of pre-rRNA in group I intron splicing is considered to be an uncomplicated or simple denominator for calculating the splicing interference or relative splicing activity in the presence of above RNA binders or splicing modulators.
| Original language | English |
|---|---|
| Pages (from-to) | 74-76 |
| Number of pages | 3 |
| Journal | Clinica Chimica Acta |
| Volume | 400 |
| Issue number | 1-2 |
| DOIs | |
| State | Published - Feb 2009 |
| Externally published | Yes |
ASJC Scopus Subject Areas
- Biochemistry
- Clinical Biochemistry
- Biochemistry, medical
Keywords
- Caffeine
- Group I intron
- Splicing inhibitors
- Tetrahymena
- Theobromine
- Theophylline
- Introns/genetics
- Biocatalysis/drug effects
- Tetrahymena thermophila/enzymology
- DNA, Ribosomal/genetics
- Drug Discovery
- RNA, Ribosomal/genetics
- Dose-Response Relationship, Drug
- Animals
- Xanthines/metabolism
- Transcription, Genetic/drug effects
- Biological Products/metabolism
- RNA Splicing/drug effects
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS